Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 21 (3), 239-57

Psychostimulants in the Treatment of Depression : A Review of the Evidence

Affiliations
Review

Psychostimulants in the Treatment of Depression : A Review of the Evidence

Katy Orr et al. CNS Drugs.

Abstract

Psychostimulants have euphoric and alerting properties that suggest their usefulness in treating depressive disorders; however, problems with tolerance and dependence with some drugs militate against their widespread therapeutic use where more acceptable licensed alternatives are available. The introduction of modafinil, a stimulant not associated with tolerance and dependence, has re-awakened interest in psychostimulants as antidepressants. The available literature, while containing somewhat inconsistent data of rather poor quality, does suggest that psychostimulants have useful antidepressant properties and are usually well tolerated. They may be useful as adjuncts to standard antidepressants in refractory depression, but have particular utility in conditions where a prompt therapeutic effect is desired and where tolerance and dependence are less of a concern. Such conditions include the treatment of depression in terminal illness and in extreme old age.Psychostimulants, although now largely discarded as treatment options for depression, deserve careful consideration as potential therapeutic agents in specific patient subgroups.

Similar articles

See all similar articles

Cited by 7 PubMed Central articles

See all "Cited by" articles

References

    1. J Pain Symptom Manage. 1998 Sep;16(3):193-8 - PubMed
    1. JAMA. 1997 Oct 8;278(14):1186-90 - PubMed
    1. J Neuropsychiatry Clin Neurosci. 1991 Winter;3(1):23-7 - PubMed
    1. N Engl J Med. 2006 Apr 6;354(14):1445-8 - PubMed
    1. Psychosomatics. 1991 Spring;32(2):203-8 - PubMed

MeSH terms

Substances

LinkOut - more resources

Feedback